Wall Street Next

latest news in companies

Himax and AUO Partner to Enhance Augmented Reality Glasses with New High-Brightness Display

Tainan, Tuesday, 30 December 2025.
Debuting at CES 2026, this collaboration unveils a microdisplay boasting an impressive 350,000 nits of brightness, promising to significantly improve visual performance for next-generation wearable devices.

SoftBank Accelerates AI Strategy With $4 Billion Acquisition of DigitalBridge

Tokyo, Tuesday, 30 December 2025.
SoftBank pivots to physical infrastructure by acquiring DigitalBridge for $4 billion, securing vital data centers needed to power Masayoshi Son’s ambitious vision of Artificial Super Intelligence.

Bunker Hill Mining Preserves Cash by Issuing Shares for Interest Payments

Vancouver, Tuesday, 30 December 2025.
Bunker Hill prioritizes liquidity for its mine restart by issuing over 1.5 million shares to settle interest debts, a strategic move to preserve capital rather than depleting cash reserves.

Cramer Selects Three Top Dividend Stocks for Sustainable Income Stability

New York, Tuesday, 30 December 2025.
Emphasizing sustainable cash flow over high yield, Cramer highlights Pfizer as a ‘bond equivalent’ backed by a massive $14 billion in free cash flow.

Compass Diversified Revenue Jumps 12% as Company Tackles Financial Restatements

Westport, Monday, 29 December 2025.
Despite a 12% revenue surge to $478.7 million, Compass Diversified faces continued net losses and regulatory hurdles linked to the Lugano bankruptcy fallout.

NextNRG Partners with A123 Systems to Scale Domestic Battery Production

Novi, Monday, 29 December 2025.
NextNRG joins forces with A123 Systems to deploy U.S.-manufactured battery storage, aiming to bypass import tariffs and secure supply chains without requiring upfront capital for new manufacturing facilities.

Inspire Medical Systems Sets Strategic Update for J.P. Morgan Healthcare Conference

Minneapolis, Monday, 29 December 2025.
Inspire Medical Systems (NYSE: INSP) is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, offering a pivotal update for the investment community. This presentation comes at a critical juncture for the Minneapolis-based medical technology firm. While Inspire recently reported robust Q3 2025 financials—including a 10% revenue increase to $224.5 million and raised full-year guidance—the company is simultaneously navigating shareholder litigation regarding its Inspire V launch. With the stock trading around $95.47 as of late December 2025, investors will be keenly focused on management’s strategy to sustain growth in the obstructive sleep apnea market while addressing these operational and legal headwinds.

Orion Group Enhances Financial Flexibility with New $120 Million Credit Agreement

Houston, Monday, 29 December 2025.
By securing this $120 million facility, Orion reduces borrowing costs by approximately 225 basis points, bolstering liquidity to capitalize on a 42% year-to-date stock surge.

Greenwich LifeSciences Leadership Extends Share Lock-Up Through 2026, Signaling Confidence in Clinical Trials

Stafford, Monday, 29 December 2025.
Directors voluntarily extended share restrictions through September 2026. This unprecedented six-year lock-up underscores strong insider confidence in the FLAMINGO-01 breast cancer trial’s potential.

Adlai Nortye Secures $230 Million Deal to Accelerate Cancer Drug Development in China

North Brunswick, Monday, 29 December 2025.
Adlai Nortye partners with ASK Pharm in a deal valued at $230 million to develop the AN9025 cancer therapy in Greater China, aiming for clinical trials in early 2026.